Carbon nanomaterials as carriers for the anti-cancer drug doxorubicin: a review on theoretical and experimental studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Carbon nanomaterials as carriers for the anti-cancer drug doxorubicin: a review on theoretical and experimental studies

Published:2024 Issue:16 Volume:6 Page:3992-4014
ISSN:2516-0230
Container-title:Nanoscale Advances
language:en
Short-container-title:Nanoscale Adv.

Author:

Gayathri K.¹²^ORCID,Vidya R.¹²^ORCID

Affiliation:

1. Centre for Materials Informatics(C-mAIn), Sir. C.V. Raman Science Block, Anna University, Sardar Patel Road, Guindy, Chennai 600 025, India

2. Department of Physics, Anna University, Sardar Patel Road, Guindy, Chennai 600 025, India

Abstract

Effect of Doxorubicin on cancer cells.

Funder

Science and Engineering Research Board

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/NA/D4NA00278D

Reference107 articles.

1. 2022 FDA approvals

2. R. W.Ruddon , Cancer Biology , Oxford University Press , 4th edn, 2007

3. Doxorubicin: The Good, the Bad and the Ugly Effect

4. Doxorubicin pathways

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP